BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 17887779)

  • 1. Measuring raft size as a function of membrane composition in PC-based systems: Part II--ternary systems.
    Brown AC; Towles KB; Wrenn SP
    Langmuir; 2007 Oct; 23(22):11188-96. PubMed ID: 17887779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring raft size as a function of membrane composition in PC-based systems: Part 1--binary systems.
    Brown AC; Towles KB; Wrenn SP
    Langmuir; 2007 Oct; 23(22):11180-7. PubMed ID: 17887778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid rafts have different sizes depending on membrane composition: a time-resolved fluorescence resonance energy transfer study.
    de Almeida RF; Loura LM; Fedorov A; Prieto M
    J Mol Biol; 2005 Mar; 346(4):1109-20. PubMed ID: 15701521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution mapping of phase behavior in a ternary lipid mixture: do lipid-raft phase boundaries depend on the sample preparation procedure?
    Buboltz JT; Bwalya C; Williams K; Schutzer M
    Langmuir; 2007 Nov; 23(24):11968-71. PubMed ID: 17949025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol dynamics in membranes of raft composition: a molecular point of view from 2H and 31P solid-state NMR.
    Aussenac F; Tavares M; Dufourc EJ
    Biochemistry; 2003 Feb; 42(6):1383-90. PubMed ID: 12578350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temperature and cholesterol composition-dependent behavior of 1-myristoyl-2-[12-[(5-dimethylamino-1-naphthalenesulfonyl)amino]dodecanoyl]-sn-glycero-3-phosphocholine in 1,2-dimyristoyl-sn-glycero-3-phosphocholine membranes.
    Troup GM; Wrenn SP
    Chem Phys Lipids; 2004 Sep; 131(2):167-82. PubMed ID: 15351269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescent probe partitioning in giant unilamellar vesicles of 'lipid raft' mixtures.
    Juhasz J; Davis JH; Sharom FJ
    Biochem J; 2010 Sep; 430(3):415-23. PubMed ID: 20642452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The polar nature of 7-ketocholesterol determines its location within membrane domains and the kinetics of membrane microsolubilization by apolipoprotein A-I.
    Massey JB; Pownall HJ
    Biochemistry; 2005 Aug; 44(30):10423-33. PubMed ID: 16042420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoscale phase separation in DSPC-cholesterol systems.
    Brown AC; Wrenn SP
    Langmuir; 2013 Aug; 29(31):9832-40. PubMed ID: 23876059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Membrane Lipid Composition on the Formation of Lipid Ultrananodomains.
    Pathak P; London E
    Biophys J; 2015 Oct; 109(8):1630-8. PubMed ID: 26488654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microdomains in lipid vesicles: structure and distribution assessed by small-angle neutron scattering.
    Vogtt K; Jeworrek C; Garamus VM; Winter R
    J Phys Chem B; 2010 Apr; 114(16):5643-8. PubMed ID: 20369805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of cholesterol and ergosterol on membrane dynamics: a fluorescence approach.
    Arora A; Raghuraman H; Chattopadhyay A
    Biochem Biophys Res Commun; 2004 Jun; 318(4):920-6. PubMed ID: 15147960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between sterol/steroid structure and participation in ordered lipid domains (lipid rafts): implications for lipid raft structure and function.
    Wang J; Megha ; London E
    Biochemistry; 2004 Feb; 43(4):1010-8. PubMed ID: 14744146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane lipid domains and rafts: current applications of fluorescence lifetime spectroscopy and imaging.
    de Almeida RF; Loura LM; Prieto M
    Chem Phys Lipids; 2009 Feb; 157(2):61-77. PubMed ID: 18723009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray kinematography of phase transformations of three-component lipid mixtures: a time-resolved synchrotron X-ray scattering study using the pressure-jump relaxation technique.
    Jeworrek C; Pühse M; Winter R
    Langmuir; 2008 Oct; 24(20):11851-9. PubMed ID: 18767826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid structural requirements for stabilizing or disrupting lipid domains.
    Wenz JJ; Barrantes FJ
    Biochemistry; 2003 Dec; 42(48):14267-76. PubMed ID: 14640695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence-quenching and resonance energy transfer studies of lipid microdomains in model and biological membranes.
    Silvius JR; Nabi IR
    Mol Membr Biol; 2006; 23(1):5-16. PubMed ID: 16611577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase separation is induced by phenothiazine derivatives in phospholipid/sphingomyelin/cholesterol mixtures containing low levels of cholesterol and sphingomyelin.
    Hendrich AB; Michalak K; Wesołowska O
    Biophys Chem; 2007 Oct; 130(1-2):32-40. PubMed ID: 17662517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined AFM and two-focus SFCS study of raft-exhibiting model membranes.
    Chiantia S; Ries J; Kahya N; Schwille P
    Chemphyschem; 2006 Nov; 7(11):2409-18. PubMed ID: 17051578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingomyelin/phosphatidylcholine/cholesterol monolayers--analysis of the interactions in model membranes and Brewster Angle Microscopy experiments.
    Wydro P
    Colloids Surf B Biointerfaces; 2012 May; 93():174-9. PubMed ID: 22277747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.